Application Nr Approved Date Route Status External Links
ANDA078033 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Oxandrolone Tablets, Usp Are Indicated As Adjunctive Therapy To Promote Weight Gain After Weight Loss Following Extensive Surgery, Chronic Infections, Or Severe Trauma, And In Some Patients Who Without Definite Pathophysiologic Reasons Fail To Gain Or To Maintain Normal Weight, To Offset The Protein Catabolism Associated With Prolonged Administration Of Corticosteroids, And For The Relief Of The Bone Pain Frequently Accompanying Osteoporosis (See Dosage And Administration ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Oxandrolone OXANDROLONE ZINC3813047

Comments